Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
Clinical trial NCT02808975 · COMPLETED
Trial details
- NCT number
- NCT02808975
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-18
- Primary completion
- 2019-05-16
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.